These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27590242)

  • 1. The role of serum levels of microRNA-21 and matrix metalloproteinase-9 in patients with acute coronary syndrome.
    Darabi F; Aghaei M; Movahedian A; Pourmoghadas A; Sarrafzadegan N
    Mol Cell Biochem; 2016 Nov; 422(1-2):51-60. PubMed ID: 27590242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum microRNA-21 levels with Visfatin, inflammation, and acute coronary syndromes.
    Darabi F; Aghaei M; Movahedian A; Elahifar A; Pourmoghadas A; Sarrafzadegan N
    Heart Vessels; 2017 May; 32(5):549-557. PubMed ID: 27785570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
    Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
    J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
    Zeng B; Prasan A; Fung KC; Solanki V; Bruce D; Freedman SB; Brieger D
    Intern Med J; 2005 Jun; 35(6):331-5. PubMed ID: 15892761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood levels of matrix and inflammatory mediators are elevated in Tunisian patients with acute coronary syndromes.
    Zayani Y; Allal-Elasmi M; Jacob MP; Zidi W; Zaroui A; Feki M; Mourali S; Mechmech R; Kaabachi N
    Clin Lab; 2013; 59(1-2):169-75. PubMed ID: 23505923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor.
    Idriss NK; Lip GY; Balakrishnan B; Jaumdally R; Boos CJ; Blann AD
    Thromb Haemost; 2010 Nov; 104(5):1029-37. PubMed ID: 20838751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome.
    Gómez-Hernández A; Sánchez-Galán E; Ortego M; Martín-Ventura JL; Blanco-Colio LM; Tarín-Vicente N; Jiménez-Nacher JJ; López-Bescos L; Egido J; Tuñón J
    Am J Cardiol; 2008 Jul; 102(1):12-8. PubMed ID: 18572029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Analysis of Acute Coronary Syndrome with Serum IL-18, MMP-9, hs-CRP, and Plasma FIB.
    Yang Y; Li G; Zhang R
    Biomed Res Int; 2022; 2022():5984184. PubMed ID: 35028315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative Association of Circulating MicroRNA-126 with High-sensitive C-reactive Protein and Vascular Cell Adhesion Molecule-1 in Patients with Coronary Artery Disease Following Percutaneous Coronary Intervention.
    Wang JN; Yan YY; Guo ZY; Jiang YJ; Liu LL; Liu B
    Chin Med J (Engl); 2016 Dec; 129(23):2786-2791. PubMed ID: 27900989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical implications of increased cyclophilin A levels in patients with acute coronary syndromes.
    Yan J; Zang X; Chen R; Yuan W; Gong J; Wang C; Li Y
    Clin Chim Acta; 2012 Apr; 413(7-8):691-5. PubMed ID: 22209965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Relevance of matrix metalloproteinase 9 in patients with acute coronary syndrome.
    Hamed GM; Fattah MF
    Clin Appl Thromb Hemost; 2015 Nov; 21(8):705-11. PubMed ID: 25616488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum MMP-9 Diagnostics, Prognostics, and Activation in Acute Coronary Syndrome and Its Recurrence.
    Lahdentausta L; Leskelä J; Winkelmann A; Tervahartiala T; Sorsa T; Pesonen E; Pussinen PJ
    J Cardiovasc Transl Res; 2018 Jun; 11(3):210-220. PubMed ID: 29349668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of atherosclerotic plaque stability and inflammation in the pathogenesis of acute coronary syndrome].
    Ding SF; Zhang Y; Zhang M; Chen WQ; Chen YG; Li JF; Ji QS; Li GS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):512-4. PubMed ID: 16842667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase-9 via reversion-inducing cysteine-rich protein with Kazal motifs.
    Fan X; Wang E; Wang X; Cong X; Chen X
    Exp Mol Pathol; 2014 Apr; 96(2):242-9. PubMed ID: 24594117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressions and clinical significance of factors related to acute coronary syndrome.
    Sun H; Zhang J; Zheng Y; Shang S
    J Biol Regul Homeost Agents; 2018; 32(2):299-305. PubMed ID: 29685010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFFECT OF RELATIVE GENE EXPRESSION ON PLAQUE VULNERABILITY IN PATIENTS WITH STABLE ANGINA AND PATIENTS WITH ACUTE CORONARY SYNDROME.
    Chen N; Zhang JY; Yang SZ; Li YD
    J Biol Regul Homeost Agents; 2015; 29(2):437-41. PubMed ID: 26122234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease.
    Kaur A; Mackin ST; Schlosser K; Wong FL; Elharram M; Delles C; Stewart DJ; Dayan N; Landry T; Pilote L
    Cardiovasc Res; 2020 May; 116(6):1113-1124. PubMed ID: 31782762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of Xuezhikang on serum levels of high sensitive-C reactive protein, matrix metalloproteinase-9 and lipoprotein in patients with acute coronary syndrome].
    Huang J; Wang MH; Peng XP; Wei C; Lu J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Mar; 26(3):221-3. PubMed ID: 16613266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-9 index as a possible parameter for predicting acute coronary syndrome in diabetics.
    Popović S; Canović F; Ilić M; Rafajlovski S; Dimitrijević-Srećović V; Matanović D; Vujović S; Djordjević P; Gostiljac D
    Vojnosanit Pregl; 2015 May; 72(5):421-6. PubMed ID: 26165049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome.
    Liu DM; Yan JC; Wang CP; Chen GH; Ding S; Liu PJ; Du RZ
    Clin Chim Acta; 2008 Nov; 397(1-2):22-6. PubMed ID: 18674525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.